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Leptin is an adipocyte-secreted hormone which plays a key role in energy homeostasis. Our aim was to determine the relationship between serum
leptin and clinical and biochemical features in overweight children and adolescents. Overweight children and adolescents followed in this Unit
with serum leptin ascertained were included. Clinical, biochemical and abdominal ultrasound data were analysed. Statistical analysis was per-
formed by t test, x2, Pearson’s correlation and linear regression. One outlier of serum leptin was excluded to perform correlation and regression.
Serum leptin was determined in 357 patients. At the first visit, the mean age was 9·5 (SD 3·2) years and mean BMI z-score was 1·72 (SD 1·34) (girls
1·71 (SD 1·16); boys 1·72 (SD 1·11)). Serum leptin levels were significantly related to: sex (mean: girls 48·0 ng/ml, boys 34·4 ng/ml; P¼0·003);
Tanner stage (mean: I–II 37·0 ng/ml, III–V 45·2 ng/ml; P¼0·035); systolic blood pressure (mean: normal 41·3 ng/ml, high 44·0 ng/ml;
P¼0·009); BMI z-score (r 0·136; P¼0·010); C-peptide (r 0·17; P¼0·002); insulin (r 0·34; P,0·001); homeostasis model assessment of insulin
resistance (HOMA-IR) (r 0·25; P,0·001) and aspartate aminotransferase (r 20·12; P¼0·023). In the multivariate analysis (with leptin as the
dependent variable and sex, Tanner stage, BMI z-score, systolic blood pressure, aspartate aminotransferase, C-peptide, insulin and HOMA-IR
as independent variables), sex and BMI were determinant factors. The present study in overweight children and adolescents showed that being
female and greater BMI were significantly and independently associated with increased serum leptin. In this large cohort other associations
with leptin described in the literature can be discharged.
Leptin: Childhood overweight: Sex: Body mass index
Obesity prevalence has been increasing among children and
adolescents as it has in adults(1). In the USA, the obesity
and overweight prevalence in 2003–4 was 17·1 and 33·6 %
respectively among children and adolescents aged 2–19
years(1). In Europe, Portugal has the second highest over-
weight prevalence in children, 31·5 %, immediately after
Italy, and 11·3 % are obese(2).
Leptin is a 16 kDa peptide hormone codified by the ob gene
which is located at chromosome 7 (7q31.1)(3). It is synthesised
mainly by adipose tissue and secreted to plasma, but other tis-
sues such as the stomach, intestines, placenta and testes also
secrete leptin(4). It regulates the expression of hypothalamic
neuropeptides involved in energy metabolism by suppressing
food intake and stimulating energy expenditure(4 – 6).
At first, it was thought that human obesity might occur as a
result of lack of leptin (as in the ob/ob mouse). However, it
was found that the majority of humans did not lack leptin;
in contrast they had circulating leptin concentrations that
were highly correlated with adipose tissue mass(7).
Leptin has effects on different systems of the body: central
nervous system (inhibition of food intake, reduction of adipose
mass, increased thermogenesis), glucose homeostasis, repro-
ductive system (signalling onset of puberty, maintenance of
reproductive function), autonomic nervous system, haemato-
poietic system, skeletal system, oncogenesis and transplantation
(contributing to rejection of transplants)(4).
The aim of the present study was to determine the relation-
ship between serum leptin levels and clinical and biochemical
features in overweight children and adolescents.
Subjects and methods
Overweight children and adolescents followed in a Paediatric
Gastroenterology, Hepatology and Nutrition Unit from 1 February
1999 to 13 November 2006 who had had serum leptin levels
determined were included in the study.
Clinical assessment included detailed history and physical
examination: weight, height, Tanner stage, systolic and dias-
tolic blood pressure, waist circumference, acanthosis nigri-
cans and stretch marks. Weight measurement was performed
using two different electronic equipments according to age
(above 2 years, SECA model 763; under 2 years, SECA
model 727; SECA GmbH and Co., Hamburg, Germany).
Blood pressure was measured three times with a cuff appropri-
ate to each arm size after 5 min rest. High blood pressure
was considered when it was above the 95th percentile
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for age and sex. Waist circumference was measured by the
same physician directly over the skin at a level midway
between the lower rib margin and the iliac crest. Blood
samples were collected after an overnight fast between 08.00
and 10.00 hours and the parameters analysed included glucose,
aminotransferases (alanine aminotransferase, aspartate amino-
transferase), total cholesterol, HDL and LDL, TAG, serum
leptin, C-peptide and insulin. Leptin was measured by immu-
noradiometric assay (DSL-23100i ACTIVEw Human Leptin
IRMA; Diagnostic Systems Laboratories Inc., Webster, TX,
USA). Abdominal ultrasound was performed by the same
physician to search for steatosis: increased hepatic parenchy-
mal echotexture and vascular blurring(8). BMI was calculated
by the standard formula (kg/m2). TAG, total cholesterol,
HDL and LDL were analysed according to age and sex(9).
Overweight was defined as BMI above the 85th percentile
and obesity above the 95th percentile for age and sex accord-
ing to the Centers of Disease Control(10). BMI and waist cir-
cumference z-score were calculated(11). Insulin resistance
was determined by the homeostasis model assessment of
insulin resistance (HOMA-IR)(10). Non-alcoholic fatty liver
disease was considered in the presence of elevated amino-
transferases and/or steatosis in abdominal ultrasound, when
other causes were excluded(12).
Statistical analysis was performed in the Statistical Package
for Social Sciences (version 15.0; SPSS Inc., Chicago, IL,
USA) using t tests, x2, Pearson’s correlation and linear
regression. One outlier of serum leptin was excluded to per-
form correlation and regression. Significance was considered
when P was below 0·05.
The Ethical Committee of S. Marcos Hospital approved the
present study.
Results
The present study included 357 overweight children and
adolescents with serum leptin levels determined; 53·2 %
were girls. The median age of obesity onset was 3 years
(range 1–13 years). The majority of patients were previously
healthy; thirty-five patients had a previous diagnosis of asthma
and one patient had a previous diagnosis of diabetes mellitus.
There was a history of overweight in first-degree relatives in
62 %, arterial hypertension in 27·7 %, type 2 diabetes mellitus
in 8·8 % and dyslipidaemia in 32·9 %. At the first visit, the
mean age was 9·5 (SD 3·2) years and its distribution was simi-
lar in both sexes (girls, 9·2 years; boys, 9·7 years, P¼0·154).
The mean BMI z-score was 1·72 (SD 1·34), in girls it was 1·71
(SD 1·16) and in boys it was 1·72 (SD 1·11).
Obesity was found in 330 children and adolescents (176
girls and 154 boys) and BMI was between the 85th and
95th percentiles in twenty-seven children (fourteen girls
and thirteen boys); 19·4 % had a BMI above 30 kg/m2
and 5·9 % above 35 kg/m2. The mean waist circumference
z-score was 1·58 (SD 1·05), 30·5 % had acanthosis nigricans
and 17 % had stretch marks. There was high systolic blood
pressure in 21·6 % and high diastolic blood pressure in
6·7 % (n 274).
The blood analysis results are shown in Table 1 (9,13). There
was hyperglycaemia (.5·6 mmol/l) in 4·5 %, high total
cholesterol in 17·5 %, low HDL in 13·2 %, high LDL in
10·7 %, high TAG in 22·1 %, insulin resistance in 54·9 %,
C-peptide above 0·73 nmol/l in 47·9 % and increased leptin
levels, by sex and Tanner stage, in 93·6 %.
The abdominal ultrasound revealed steatosis in 26·7 %
(n 195). Non-alcoholic fatty liver disease was present in
46·4 % (n 224).
Serum leptin levels were significantly related to sex, Tanner
stage, systolic blood pressure, BMI z-score, C-peptide, insulin,
HOMA-IR and aspartate aminotransferase (Tables 1 and 2).
We found no correlation between serum leptin and lipid
profile or blood glucose.
In boys (n 166), leptin was significantly related to insulin
(r 0·364; P,0·001) and HOMA-IR (r 0·313; P,0·001); it was
not significantly related to BMI z-score (r 0·142; P¼0·068). In
girls (n 190), leptin levels were significantly related to Tanner
stage (mean: I–II 40·4 ng/ml, III–V 53·7 ng/ml; P¼0·009), BMI
Table 1. Associations (r; Pearson’s test) between serum leptin levels (ng/ml) and clinical and laboratory characteristics
(Mean values and standard deviations and correlation coefficients)
Mean SD r P Subjects (n) Reference values
Fasting leptin (ng/ml) 42·3 28·7 356 †
Waist circumference (cm) 86·3 12·9 0·27* ,0·001 332
Waist circumference z-score 1·58 1·05 0·10 0·059 332
BMI (kg/m2) 26·8 4·4 0·35* ,0·001 356
BMI z-score 1·72 1·34 0·136 0·010 356
Fasting glucose (mmol/l) 4·7 1·1 0·03 0·581 350 3·9–5·8
Total cholesterol (mmol/l) 4·4 0·9 0·03 0·951 324 ‡
HDL (mmol/l) 1·3 0·3 20·08 0·155 316 ‡
LDL (mmol/l) 2·6 0·8 20·09 0·179 223 ‡
TAG (mmol/l) 1·1 1·3 20·009 0·869 352 ‡
Fasting insulin (pmol/l) 98·6 143·9 0·34* ,0·001 346 41·7–187·5
HOMA-IR 3·1 5·5 0·25* ,0·001 339
Fasting C-peptide (nmol/l) 0·9 0·6 0·17* 0·002 336 0·13–0·73
Alanine aminotransferase (U/l) 27·2 38·3 20·95 0·076 348 10–34
Aspartate aminotransferase (U/l) 26·8 26·5 20·12* 0·023 346 10–44
HOMA-IR, homeostasis model assessment of insulin resistance.
*P,0·05.
† See Fisher(13).
‡ See Kliegman et al. (9).
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z-score (r 0·145;P¼0·046), C-peptide (r 0·309;P,0·001), insulin
(r 0·335; P,0·001) and HOMA-IR (r 0·248; P¼0·001).
In the multivariate analysis, with leptin as the dependent
variable and the variables with significant associations as inde-
pendent variables, being female (P¼0·012) and greater BMI
(P¼0·006) were determinant factors (Table 3). The associ-
ations between leptin and sex and between leptin and BMI
z-score are shown in Figs. 1 and 2.
After 6 months of follow-up (n 286), with dietary and exer-
cise recommendations and without any pharmacological treat-
ment, the mean z-score BMI was 1·58 (SD 1·08); in girls it was
1·57 (SD 1·11) and in boys it was 1·59 (SD 1·05). Both in girls
and in boys it was significantly lower than that at the first visit
(P,0·001 and P¼0·017 respectively) but the difference had
no correlation with serum leptin levels.
Table 2. Associations of serum leptin levels (ng/ml)
(Mean values and standard deviations)
Leptin
Mean SD P†
Sex* 0·003
Girls 48·0 27·1
Boys 34·4 22·4
Tanner stage* 0·035
I–II 37·0 22·3
III–V 45·2 29·6
Acanthosis nigricans 0·79
Present 40·1 26·4
Absent 42·4 25·9
Systolic blood pressure* 0·009
Normal 41·3 23·1
High 44·0 27·4
Diastolic blood pressure 0·11
Normal 42·0 23·9
High 43·3 29·4
Steatosis in abdominal ultrasound 0·55
Present 43·5 21·9
Absent 41·2 21·9
Non-alcoholic fatty liver disease 0·74
Present 40·9 24·0
Absent 41·9 24·8
Total cholesterol 0·35
Normal 41·7 25·7
High 38·2 24·3
HDL 0·64
Normal 41·2 26·0
Low 39·2 22·3
LDL 0·06
Normal 46·9 26·6
High 36·5 20·9
TAG 0·62
Normal 41·7 26·7
High 40·0 23·2
*P,0·05.
† By t test.
Table 3. Linear regression analysis with serum leptin as the dependent
variable
Standardised b coefficients P
Sex 0·186 0·012*
BMI z-score 0·205 0·006*
Tanner stage 0·106 0·197
Systolic blood pressure (mmHg) 0·074 0·327
Fasting insulin (pmol/l) 0·403 0·296
HOMA-IR 20·147 0·711
Fasting C-peptide (nmol/l) 20·038 0·626
Aspartate aminotransferase (U/l) 20·109 0·123
HOMA-IR, homeostasis model assessment of insulin resistance.
*P,0·05.
Fig. 1. Relationship between serum leptin concentration (ng/ml) and sex.
The central line is the mean; the box represents the lower and upper quar-
tiles; the whisker shows the maximum and minimum values; W, outliers; *
outlier excluded from analysis. The mean leptin concentration for girls was
48·0 ng/ml; for boys it was boys 34·4 ng/ml (P¼0·003; t test).
Fig. 2. Relationship between serum leptin concentration (ng/ml) and BMI
z-score (r 0·136; P¼0·010; Pearson’s test).
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Discussion
Our work shows several significant associations of clinical
and biochemical parameters with serum leptin, but in a multi-
variate analysis only being female and increased BMI
remain significant. As serum leptin correlates only with clini-
cal variables, it was excluded in the obesity protocol of the
Gastroenterology and Nutrition Unit of our Hospital after
this result.
We exhibit evidence that girls have higher leptin levels than
boys, as previously reported in obese(6,14) and non-obese(15)
children and adolescents. This difference increases through
puberty as leptin increases from Tanner stage I to V in
girls(16); this might be explained at least in part by the
higher testosterone levels in males which have a negative
effect on leptin concentrations(14,17). Our data also reveal sig-
nificantly higher leptin in Tanner stages III–V when compared
with Tanner stages I–II.
The present study confirms previous findings of a positive
correlation between serum leptin levels and BMI(5,6,14,16 – 18)
even after adjustment for age. Although it seems contra-
dictory, because high leptin concentrations should inhibit
additional increases in fat mass, this might be indicative of
leptin resistance(7).
If we compare males and females separately, BMI z-score
no longer has significant association with leptin in boys but
it can be due to the association of a weaker relationship in
boys (r 0·142) compared with girls (r 0·145) and a smaller
number of patients (166 compared with 190 girls). After
adjustment, BMI z-score remains with a positive correlation
with leptin levels.
We observed a positive association between serum leptin con-
centrations and waist circumference as previously described(5,6)
but it disappeared after adjustment for age.
The relationship between leptin levels and high systolic
blood pressure as described in boys in a former study(5) was
no longer present after adjustment.
In contrast to a significant relationship between leptin and
insulin resistance independently of body fatness described(5),
we observed a significant association between leptin and fast-
ing insulin and insulin resistance, but it also disappeared after
multivariate analysis, as these parameters were associated with
higher BMI.
It was important to perform multivariate analysis to exclude
relationships between variables other than leptin, as verified
with fasting insulin, insulin resistance, high systolic blood
pressure and greater BMI.
We found no association between leptin and lipid profile as
previous reported(6); nevertheless, there are data describing a
significant correlation with TAG(5).
Although we did not find any relationship between BMI vari-
ation at 6 months and leptin, there are small investigations that
found a negative correlation between leptin and weight gain(19)
and some other studies found higher leptin levels to predict
weight gain over time(7,20,21), which could be explained by the
relationship between higher initial BMI and less adherence to
diet and exercise and consequently weight gain, but there is one
large study (n 263) in which this relationship was independent
of initial BMI(19).
In conclusion, we confirmed that girls have higher leptin
levels than boys independently of the degree of obesity and
that fasting serum leptin has a positive correlation with BMI
independently of sex. Although leptin levels should not be
regarded a less valuable parameter because of the associations
found with anthropometrics or sex as it implicates endocrine
changes, we do not consider that serum leptin levels should
be included in the investigation protocol of our obese patients.
In this large paediatric cohort other associations with leptin
described in the literature can be discharged.
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